profit from every $100 of sales.
$0$100
Creative Medical Technology Holdings
$0.53-14.35% today
-81.3% in 1 year
1-year low $0.531-year high $3.15
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Creative Medical Technology Holdings sold, what it kept, and what it did with the cash.
Sales went from $88,600 in 2022 to $6,000 in 2025, with -$6.00 million of profit last year.
SalesProfit
Creative Medical Technology Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Creative Medical Technology Holdings | No profit yet | ||
 Vertex Pharmaceuticals | 34.5× · Expensive | ||
 Regeneron Pharmaceuticals | 21.9× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.0× · Fair price |
AI analysis
An AI analyst reads Creative Medical Technology Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | |
| -10 | -6 | -6 | -6 | |
| -10 | -6 | -6 | -6 | |
| -10 | -5 | -5 | -6 | |
| -9.28 | -3.76 | -3.71 | -2.52 | |
| 67.8% | 60.0% | 60.0% | 63.4% | |
| -11,562.5% | -62,445.9% | -52,216.9% | -102,380.2% | |
| -11,449.3% | -58,739.7% | -49,940.7% | -99,916.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 19 | 11 | 7 | 8 |
| Cash | 8 | 3 | 6 | 7 |
| Total debt | – | – | – | – |
| Total liabilities | 3 | 0 | 0 | 0 |
| 16 | 10 | 6 | 8 | |
| 1 | 1 | 1 | 2 | |
| -51.0% | -42.9% | -71.6% | -64.6% | |
| -63.9% | -51.1% | -86.6% | -79.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -8 | -8 | -5 | -6 | |
| – | 0 | 0 | – | |
| -8 | -8 | -6 | -6 | |
| Dividends paid | – | – | – | – |
| 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 |
Valuation
- –
- –
- –
- 1.4×
- 668.7×
- –
- –
- -146.0%
- -149.4%
- 0.0%
Profitability
- 63.4%
- -102,380.2%
- -99,916.8%
- -193,996.1%
- -96.9%
- -18.7%
- -88.5%
- -89.5%
- -96.9%
- 68,605.0%
Growth
- −59.2%
- –
- −10.5%
- –
- +73.9%
Financial health
- -1.2×
- 0.00
- 0.0%
- –
- 19.69
- 19.69
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 946
Bottom 1%of 867
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 8, 2026 | -0.38 | -0.39 | +2.6% |
| Mar 20, 2026 | -0.80 | -0.37 | −116.2% |
| Nov 7, 2025 | -0.48 | -0.48 | +0.0% |
| Aug 8, 2025 | -0.48 | -0.63 | +23.8% |
| May 9, 2025 | -0.83 | -0.52 | −59.6% |
| Mar 14, 2025 | -1.12 | -0.63 | −77.8% |
| Nov 8, 2024 | -0.75 | -0.85 | +11.8% |
| Aug 9, 2024 | -1.11 | -0.84 | −32.1% |
News
Adobe (ADBE) Deepens AI Partnerships Across Creative And Customer Experience ToolsYahoo Finance · Oct 21, 2026Modelo owner Constellation is getting creative to bring back beer drinkers as overall demand weakensCNBC · Oct 7, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
45No pass
Benjamin Graham
65Pass
Philip Fisher
54No pass
Peter Lynch
0No pass
Joel Greenblatt
0No pass
Charlie Munger
54No pass
Terry Smith
49No pass
Questions about Creative Medical Technology Holdings
Is Creative Medical Technology Holdings a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Creative Medical Technology Holdings AI analysis
What does Creative Medical Technology Holdings do?
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. It is in Biotechnology.
Does Creative Medical Technology Holdings pay a dividend?
No. Creative Medical Technology Holdings does not pay a dividend at the moment; in 2025 it returned $10,000 to shareholders by buying back its own shares.
Is Creative Medical Technology Holdings stock halal?
No. Creative Medical Technology Holdings does not pass our halal screen: its cash and confirmed interest-bearing investments are 180% of its market value, at or above the 33% limit. How we check
How has Creative Medical Technology Holdings stock done over the past year?
Down 81.3% over the past twelve months, to $0.53. It traded between $0.53 and $3.15 and is 83.2% below its high.
Who are Creative Medical Technology Holdings's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with Creative Medical Technology Holdings's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.